COVID-19

Views & Analysis

3d illustration and concept of international logistics of agreements and international business. Networks and companies around the world

Time for a health innovation pact: rethinking the design and...

Janssen’s Anouk De Vroey on why we need to extend the public/private partnerships resulting from COVID-19 into more high-level dialogue on health innovation with governments.

News

Chasing Regeneron, AZ starts trials of its COVID-19 antibody...

The first patients have been dosed in a trial of two AstraZeneca antibodies, collectively known as AZD7442, that are being developed to both treat and prevent coronavirus infec

News

Coronavirus vaccine: how pharma is picking up the pace

China starts vaccinating key workers against COVID-19; repor...

China has already granted emergency use authorisation to multiple COVID-19 vaccines developed by domestic drugmakers and started dosing key workers, according to local media re

News

COVID plasma treatment gets emergency license from FDA after...

The FDA has allowed a blood plasma treatment for COVID-19 to be administered under an Emergency Use license – but some have decried the move as a “political stunt” as president Trump accuses the

Views & Analysis

Coronavirus pharma news round-up 21/08/20

New insights into smell and taste loss symptoms, artificial intelligence and further encouraging data from a vaccine candidate hit the headlines this week as the COVID-19 coronavirus pandem

News

"Tokyo, Japan - May 11, 2012: Pfizer building on May 11, 2012 in Tokyo. Pfizer is one of largest pharmaceutical companies worldwide with tremendous revenue $67.4 bn USD for 2011. It exists since 1849."

Pfizer/BioNTech say COVID-19 jab on track for approval by ye...

Pfizer and BioNTech have said their COVID-19 vaccine could be ready for regulators to review by October and approved by the end of the year after releasing more favourable data from an earl

Time for a health innovation pact: rethinking the design and...

Chasing Regeneron, AZ starts trials of its COVID-19 antibody...

China starts vaccinating key workers against COVID-19; repor...

COVID plasma treatment gets emergency license from FDA after...

Coronavirus pharma news round-up 21/08/20

Pfizer/BioNTech say COVID-19 jab on track for approval by ye...

Ambrosia's sweet $100m round, and other biofinancings

Using AI-driven synthetic personas to take your insights fur...

COVID-19

Editor's Picks